Related Experiment Video
Updated: Feb 18, 2026

Using Next Generation Sequencing to Identify Mutations Associated with Repair of a CAS9-induced Double Strand Break Near the CD4 Promoter
Published on: March 31, 2022
[DNA repair as a therapeutic target]
Lauriane Eberst1, Medhi Brahmi1, Philippe A Cassier1
1Centre Léon-Bérard, département de médecine, 28, rue Laennec, 69008 Lyon, France.
Abstract:
The transmission of an intact and stable genetic code at each cell division relies on different DNA repair systems. Germline mutations of some of these genes cause cancer predisposition, whereas somatic mutations are frequently found in various cancer types, generating genomic instability. As a consequence, cancer cell becomes more susceptible to additional DNA damage. Pharmacological inhibition of DNA repair pathways exploits this frailty: it triggers more damages than cancer cell can tolerate, finally leading to apoptosis. The success of PARP (poly-ADP-ribose polymerase) inhibitors in BRCA1/2-mutated ovarian cancer shows the clinical relevance of this strategy. Herein, we explain the functioning of different DNA-repair pathways, describe the implicated proteins, and their close relation with cell-cycle checkpoints. We focus on novel therapeutic agents targeting DNA repair, their clinical results, and discuss challenges of combination therapies.
Insights
DNA repair pathways are crucial for genetic stability. Inhibiting these pathways in cancer cells, which are already unstable, can lead to apoptosis, offering a promising therapeutic strategy.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- DNA repair systems ensure genetic code stability during cell division.
- Mutations in DNA repair genes can lead to cancer predisposition and genomic instability in cancer cells.
- Cancer cells' increased susceptibility to DNA damage presents a therapeutic vulnerability.
Purpose of the Study:
- To elucidate the mechanisms of various DNA repair pathways.
- To detail the proteins involved in DNA repair and their link to cell-cycle checkpoints.
- To review novel therapeutic agents targeting DNA repair, their clinical outcomes, and combination therapy challenges.
Main Methods:
- Review of DNA repair pathways and associated proteins.
- Analysis of cell-cycle checkpoint interactions with DNA repair.
- Examination of clinical data for novel DNA repair-targeting agents.
Main Results:
- DNA repair pathways are essential for maintaining genomic integrity.
- Defects in DNA repair pathways contribute to cancer development and progression.
- Targeting DNA repair, such as with PARP inhibitors in BRCA-mutated cancers, demonstrates clinical efficacy.
Conclusions:
- Exploiting cancer cell DNA repair deficiencies offers a viable therapeutic approach.
- Novel agents targeting DNA repair pathways show promise in cancer treatment.
- Further research into combination therapies is needed to overcome resistance and improve outcomes.
Related Concept Videos
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Overview of DNA Repair
Chemically...
Overview of DNA Repair
Long-patch Base Excision Repair
Base Excision Repair
The first step of...

